Systemic opioid use and total healthcare costs are reduced following spinal cord stimulation therapy

Takeaway

  • Continuing spinal cord stimulation therapy for at least 2 years allows the reduction or discontinuation of systemic opioids and lowers overall costs.

Why this matters

    There is a widely recognized need to reduce opioid use for chronic pain, yet few studies have investigated patterns of systemic opioid use among recipients of spinal cord stimulation therapy. These novel findings suggest that spinal cord stimulation could provide a cost-effective alternative for reducing or eliminating opioid consumption in a substantial proportion of individuals affected by chronic pain.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.